Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5279024
Max Phase: Preclinical
Molecular Formula: C14H9ClN2O2S
Molecular Weight: 304.76
Associated Items:
ID: ALA5279024
Max Phase: Preclinical
Molecular Formula: C14H9ClN2O2S
Molecular Weight: 304.76
Associated Items:
Canonical SMILES: O=C(Nc1nccs1)c1ccc(-c2cccc(Cl)c2)o1
Standard InChI: InChI=1S/C14H9ClN2O2S/c15-10-3-1-2-9(8-10)11-4-5-12(19-11)13(18)17-14-16-6-7-20-14/h1-8H,(H,16,17,18)
Standard InChI Key: QORJPMCZSMSFII-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 304.76 | Molecular Weight (Monoisotopic): 304.0073 | AlogP: 4.31 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.00 | CX Basic pKa: | CX LogP: 3.64 | CX LogD: 3.64 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.78 | Np Likeness Score: -2.38 |
1. He M, Li YJ, Shao J, Li YS, Cui ZN.. (2023) Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α-glucosidase inhibitors., 83 [PMID:36764471] [10.1016/j.bmcl.2023.129173] |
Source(1):